top of page
Search Results

581 items found for "G-protein coupled receptors (GPCRs)"

  • 📰 GPCR Weekly News, March 18 to 24, 2024

    Calcium-Driven In Silico Inactivation of a Human Olfactory Receptor Deciphering the role of glycosaminoglycans in GPCR signaling G protein-coupled receptor-mediated autophagy in health and disease GPCR Binders, vivo through inhibiting CREB-ALK5-mediated endothelial to mesenchymal transition Role of pH-sensing receptors G proteins on endosomes and other organelles Reviews, GPCRs, and more G protein-coupled receptor (GPCR and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein

  • Odorant receptors – a bit of smell for drug discovery

    Odorant receptors function and expression landscape Odorant receptors (ORs) belong to the G protein-coupled receptor (GPCR) family and are the largest known mammalian gene family with around 900 genes. OR51E1 and OR51E2, initially assumed to be GPCRs only expressed in prostate tissue, play a role in prostate compounds, there has been a growing interest from the scientific community to target this class of GPCRs Check the original article at https://pubmed.ncbi.nlm.nih.gov/35999088/ #GPCR #DrGPCR#Ecosystem

  • Combined docking and machine learning identify key molecular determinants of ligand pharmacological

    September 2022 "G proteincoupled receptors (GPCRs) are valuable therapeutic targets for many diseases A central question of GPCR drug discovery is to understand what determines the agonism or antagonism We hypothesized that there is a common set of receptor interactions made by ligands of diverse structures β2AR structures, generating ca 75 000 docking poses and predicted all atomic interactions between the receptor Read more at the source #DrGPCR #GPCR #IndustryNews

  • Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...

    Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion of mesenchymal Chemokines are low molecular weight proteins that their functional activities are achieved by binding to the cell surface G protein-coupled receptors (GPCRs). Chemokine and chemokine receptors are of the most important and effective molecules in MSC trafficking Chemokine/chemokine receptor axes play a pivotal role in the recruitment and oriented trafficking of

  • Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinet

    Luciferase-based GloSensor™ cAMP assay: Temperature optimization and application to cell-based kinetic studies "G protein-coupled receptors (GPCRs) are an important receptor superfamily and common therapeutic targets The GloSensor™ cAMP assay enables real-time monitoring of signaling downstream of many GPCRs. optimization studies were carried out using HEK293H cells transiently transfected with the adenosine receptor for drug discovery" Read more at the source #DrGPCR #GPCR #IndustryNews

  • Genome-scale CRISPR screening reveals that C3aR signaling is critical for rapid capture of fungi...

    macrophages, including the ragulator complex (involved in nutrient stress sensing), glycosylation enzymes, protein The highest scoring protective hits included the complement C3a receptor (C3aR), a G-protein coupled receptor (GPCR) that recognizes the complement fragment C3a. Read more at the source #DrGPCR #GPCR #IndustryNews

  • Diversification of PAR signaling through receptor crosstalk

    October 2022 "Protease activated receptors (PARs) are among the first receptors shown to transactivate other receptors: noticeably, these interactions are not limited to members of the same family, but involve receptors as diverse as receptor kinases, prostanoid receptors, purinergic receptors and ionic channels the evidence for PAR interactions with members of their own family, as well as with other types of receptors Read more at the source #DrGPCR #GPCR #IndustryNews

  • Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...

    Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall webworm Hyphantria cunea Background: Insect G protein-coupled receptors (GPCRs) have been identified as a new generation HLGR2 is a typical GPCR and shows high structural and sequence similarity with other insect LGR2 proteins

  • Protein Uncoupling as an Innovative Practice in Diabetes Mellitus Treatment: A Metabolic Disorder

    October 2022 "Background: Uncoupling proteins (UCPs) are unpaired electron carriers that uncouple oxygen hypothesised to be triggered by superoxide and then reduce mitochondrial free radical production, potentially protecting Objectives: The objectives of the study are to find out the newest ways to treat diabetes mellitus through protein Read more at the source #DrGPCR #GPCR #IndustryNews

  • Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery

    “ A substitution of one amino acid by another in a protein can have effects ranging from negligible to This technique has uncovered fundamental aspects of the G protein-coupled receptor (GPCR) function, including G-protein coupled receptors: models, mutagenesis, and drug design. Molecular determinants of ligand efficacy and potency in GPCR signaling. Flipping the GPCR switch: Structure-based development of selective cannabinoid receptor 2 inverse agonists

  • Functional modulation of PTH1R activation and signaling by RAMP2

    September 2022 "Receptor-activity-modifying proteins (RAMPs) are ubiquitously expressed membrane proteins that associate with different G proteincoupled receptors (GPCRs), including the parathyroid hormone 1 receptor (PTH1R), a class B GPCR and an important modulator of mineral ion homeostasis and bone metabolism However, it is unknown whether and how RAMP proteins may affect PTH1R function. Read more at the source #DrGPCR #GPCR #IndustryNews

  • Domain Therapeutics Raises $42m Series A Financing

    biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology, announced today the closing of a US $42m (€39m) Read more at the source #DrGPCR #GPCR #IndustryNews

  • Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes

    This concept is gaining significant attention in drug discovery, especially in the context of G protein-coupled receptors (GPCRs) like the glucagon-like peptide-1 receptor (GLP-1R). It is primarily coupled to the Gs protein, which leads to the production of cyclic AMP (cAMP). Additionally, GLP-1R couple to G protein-coupled receptor kinases (GRKs) and recruit β-arrestins, adding McNeill, S.M., et al., The role of G protein-coupled receptor kinases in GLP-1R β-arrestin recruitment

  • GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS

    APRIL 06 - 09, 2022 | | SNOWBIRD RESORT, UTAH, UNITED STATES The superfamily of G protein-coupled receptors Coupled with their ability to respond to a highly diverse range of chemical stimuli, they represent the mechanisms of GPCR function has revealed new paradigms with increasingly complex models of receptor GPCRs as environmental sensors; 3. The structural basis for GPCR activation of down-stream signaling and regulatory proteins; and 4.

  • Structural landscape of the Chemokine Receptor system

    Chemokine receptors (CKRs) belong to a subfamily of G-protein-coupled receptors (GPCRs) and play a crucial CKRs can be classified into typical CKRs, atypical CKRs (ACKRs) which lack G-protein signaling, and viral Currently, there are more than 40 available structures of chemokines and their receptors in the Protein core to make room for the G-protein (Lu, Zhao et al. 2022). It has been demonstrated that the shorter truncation variant, CCL15L, exhibits bias toward G-protein

  • Activation of the human chemokine receptor CX3CR1 regulated by cholesterol

    August 2022 "As the only member of the CX3C chemokine receptor subfamily, CX3CR1 binds to its sole endogenous A much smaller conformational change of helix VI upon activation than previously solved class A GPCR-Gi Thus, our data deepen the understanding of cholesterol modulation in GPCR (G protein-coupled receptor ) signaling and provide insights into the diversity of G protein coupling." Read more at the source #DrGPCR #GPCR #IndustryNews

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    identification of binding pathways and two distinct high-affinity sites for succinate in succinate receptor 1/GPR91 Specific pharmacological and Gi/o protein responses of some native GPCRs in neurons Beyond the Nucleus: Plastic Chemicals Activate G Protein-Coupled Receptors GPCRs in Neuroscience A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator VU0486846 reduces neurogliosis in female and Exhibition June 2 - 7, 2024 | Chemotactic Cytokines June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein

  • Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist

    . 30, 2021 -- Orion Biotechnology, a clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel drug modality, proven discovery platform and best-in-class OB-004 is a GPCR targeted protein analog of CCL2 that targets the CCR2 receptor. Read more at the source #DrGPCR #GPCR #IndustryNews

  • 📰 GPCR Weekly News, January 1 to 7, 2024

    Adhesion GPCRs The adhesion G-protein-coupled receptor mayo/CG11318 controls midgut development in Drosophila Proinflammatory chemokine CXCL14 activates MAS-related G protein-coupled receptor MRGPRX2 and its putative via P2X4 receptor] Osmotic stress studies of G-protein-coupled receptor rhodopsin activation GPCR Binders by the Tre1/S1pr1 phospholipid-binding G protein-coupled receptor Methods & Updates in GPCR Research in various states Reviews, GPCRs, and more G Protein-coupled Receptors (GPCRs) as Potential Therapeutics

  • The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells

    abundant signaling compounds; their influence predominantly arises via engagement with the principal two G-protein-coupled cannabinoid receptors, CB1 and CB2. Earlier publications have indicated that expression of CB1 receptor mRNA and protein has been recognized This can be deduced from the qRT-PCR assays; triggering CB1 receptors amplifies both NR4A1 and NR4A3 Read more at the source #DrGPCR #GPCR #IndustryNews

  • Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...

    Meanwhile, cGAS deletion upregulated profibrotic Yes-associated protein (YAP) signaling in endothelial Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717, and a G protein-coupled receptor (GPCR)-based antagonist that blocks the profibrotic activity of endothelial Read more at the source #DrGPCR #GPCR #IndustryNews

  • Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology

    March 2022 "Explicyte grants Domain Therapeutics exclusivity on data related to GPCR implicated in immunoresistance Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology (IO), and Explicyte, an expert in the field of IO The two companies will combine their expertise to identify GPCR targets and associated biomarkers to Read more at the source #DrGPCR #GPCR #IndustryNews

  • TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi

    G proteins?. homology, coupled to different families of G proteins, so the comparison and structural analysis of In the same way, as in other GPCRs-G protein complexes, the structural analysis revealed that electrostatic interactions are crucial for the coupling of G-proteins to serotonin receptors. of the receptor to the G protein.

  • Orion Shares New Data on its Latest Best-in-Class Drug Candidate

    Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs), today announced that it will be presenting important new data at both Vice-President Drug Discovery, will present Orion’s novel technology for targeting undrugged peptidergic GPCRs discovery platform, one of the fastest drug discovery solutions in the industry for targeting peptidergic GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

  • Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets

    orally available small molecules aimed at intractable and poorly drugged membrane and complex-bound protein The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute Read more at the source #DrGPCR #GPCR #IndustryNews

  • All Aboard the GPCR Express: Your Weekly Update is here! Oct 14-20, 2024

    Protein-Coupled Receptors Avoid delaying it further! mechanosensing   GPCR Activation and Signaling Opioid receptors reveal a discrete cellular mechanism of endosomal G protein activation Amylin receptor subunit interactions are modulated by agonists and determine signaling Distinct role of GRK3 in platelet activation by desensitization of G protein-coupled The Class F of G Protein-Coupled Receptors Structural and Molecular Insights into GPCR Function Structure

  • Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs)...

    September 2022 Regulator of G Protein Signaling 20 Correlates with Long Intergenic Non-Coding RNA (lincRNAs Interestingly, RGS (Regulators of G protein signaling) proteins, which negatively regulate GPCR signaling Our analysis further supports the putative function of RGS proteins, particularly RGS20, in cancer." Read more at the source #DrGPCR #GPCR #IndustryNews

  • 📰 GPCR Weekly News, May 1 to 7, 2023

    GPCR Activation and Signaling Constitutive activity of the dopamine (D5 ) receptor, highly expressed protein-coupled receptor. GPCRs in Neuroscience GPCR interactions involving metabotropic glutamate receptors and their relevance G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Structural and Molecular Insights into GPCR Function Structural insight into an anti-BRIL Fab as a G-protein-coupled

bottom of page